C. Logothetis

4.7k citations
73 papers · 2.6k · 1 hit paper · h-index 23

Impact in

Papers in

C. Logothetis

71 papers receiving 2.4k citations

C. Logothetis's Hit Papers

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. 1990 · 490 citations
4900+12+24Years since publication100200300400

Peers

C. Logothetis
Comparison fields: 5 of 82
  • Pulmonary and Respiratory Medicine 969
  • Oncology 665
  • Surgery 1.0k
  • Cancer Research 347
  • Urology 78
Replace Avishay Sella with:
Avishay Sella United States
Danai Daliani United States
R. J. Amato United States
Stéphane Culine France
Warren Chow United States
Joseph T. Spaulding United States
Tracy Curley United States
Lisa Sengeløv Denmark
Simon J. Crabb United Kingdom
Dominik Berthold Switzerland
C. Logothetis relative to Avishay Sella United States Avishay Sella's profile →
Citations per field
00.5×1.5×
Avishay Sella · 1×
Citations per year

Countries citing papers authored by C. Logothetis

Since Specialization
Citations

This map shows the geographic impact of C. Logothetis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Logothetis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Logothetis more than expected).

Fields of papers citing papers by C. Logothetis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Logothetis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Logothetis. The network helps show where C. Logothetis may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Logothetis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Logothetis Line = papers co-authored together C. Logothetis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.
Hit paper breakdown →
1990490
2 2003230
3 1992213
4 1988130
5 2011112
6 1993110
7 1985107
8 199499
9 199091
10 201187
11 201674
12 198566
13
NCCN Practice Guidelines for Prostate Cancer.
200059
14 200755
15 198352
16 198949
17 199845
18 200941
19 201134
20 200830

About C. Logothetis

C. Logothetis is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 73 papers that have together received 2.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (38 papers), Radiopharmaceutical Chemistry and Applications (12 papers), Testicular diseases and treatments (11 papers), Cancer Treatment and Pharmacology (10 papers), Bone health and treatments (9 papers), Bladder and Urothelial Cancer Treatments (6 papers), Cancer, Lipids, and Metabolism (6 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (969 citations), Oncology (665 citations), Surgery (1.0k citations), Cancer Research (347 citations) and Urology (78 citations). C. Logothetis has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Avishay Sella, R. J. Amato, F. H. Dexeus, Robert G. Kilbourn, Alberto G. Ayala, Laura Finn, Douglas E. Johnson, Andrew C. von Eschenbach, Randall E. Millikan and David A. Swanson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Oncogene, The Journal of Urology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact